Statement: the primary clinical trial intervention protocol will be ceased before a patient achieves complete response or suffers from disease progression
Primary_evidence: INTERVENTION 1:    Pemetrexed   600 mg/m2, intravenous (IV), every 14 days until complete response or disease progression